Quick Answer
VOLITIONRX LTD reported Stockholders Equity of -$34.25 million for fiscal year 2025.
VOLITIONRX LTD Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$34.25M | -37.5% |
| 2024 | -$24.91M | -219.2% |
| 2023 | -$7.80M | -203.0% |
| 2022 | -$2.57M | -114.5% |
| 2021 | $17.72M | +8.8% |
| 2020 | $16.29M | +14.8% |
| 2019 | $14.20M | +17.0% |
| 2018 | $12.14M | +21.9% |
| 2017 | $9.96M | -53.0% |
| 2016 | $21.18M | +250.3% |
| 2015 | $6.04M | +1541.7% |
| 2014 | $368.2K | -45.9% |
| 2013 | $680.7K | -18.4% |
| 2012 | $833.8K | -23.4% |
| 2011 | $1.09M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$34.64M | -61.1% | -8.9% |
| June 30, 2025 | -$31.82M | -45.9% | -14.6% |
| March 31, 2025 | -$27.77M | -78.0% | -11.5% |
| December 31, 2024 | -$24.91M | -219.2% | -15.8% |
| September 30, 2024 | -$21.50M | -952.7% | +1.4% |
| June 30, 2024 | -$21.81M | -473.2% | -39.7% |
| March 31, 2024 | -$15.61M | -568.1% | -100.0% |
| December 31, 2023 | -$7.80M | -203.0% | -281.9% |
- VOLITIONRX LTD showed a decrease of -37.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, VOLITIONRX LTD’s stockholders equity has declined by 3244.9% (from $1.09 million to -$34.25 million).
- The most recent figure is from VOLITIONRX LTD’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: